In vivo delivery of engineered synthetic DNA-encoded SARS-CoV-2 monoclonal antibodies for pre-exposure prophylaxis in non-human primates

COVID-19 remains a major public health concern. Monoclonal antibodies have received emergency use authorization (EUA) for pre-exposure prophylaxis against COVID-19 among high-risk groups for treatment of mild to moderate COVID-19. In addition to recombinant biologics, engineered synthetic DNA-encode...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Patel, Ami, Rosenke, Kyle, Parzych, Elizabeth M., Feldmann, Friederike, Bharti, Suman, Griffin, Amanda J., Schouest, Blake, Lewis, Matt, Choi, Jihae, Chokkalingam, Neethu, Machado, Viviane, Smith, Brian J., Frase, Drew, Ali, Ali R., Lovaglio, Jamie, Nguyen, Brian, Hanley, Patrick W., Walker, Susanne N., Gary, Ebony N., Kulkarni, Abhijeet, Generotti, Allison, Francica, Joseph R., Rosenthal, Kim, Kulp, Daniel W., Esser, Mark T., Smith, Trevor R. F., Shaia, Carl, Weiner, David B., Feldmann, Heinz
Format: Dataset
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!